Volastra Therapeutics, a clinical-stage oncology company pioneering therapies targeting chromosomal instability (CIN), today ...

Validated biomarkers will help physicians identify patient subgroups that will benefit most from specific treatment ...

“Fasting insulin is one of the most crucial — and most overlooked — biomarkers in medicine because it reveals how hard your ...

Current research investigates novel biomarkers that can predict therapeutic outcomes. Finding ways to determine therapeutic ...

The levels of apurinic/apyrimidinic endodeoxyribonuclease 1 varied significantly between patients with cholangiocarcinoma, hepatocellular carcinoma, benign biliary disorders, and healthy people.

Determining the presence of a protein in non-tumor cells within the cancer microenvironment could be one of the keys to establishing prognosis in patients with colon and rectal cancer.

Advocates fear New York state could be taking a step back when it comes to biomarker testing access for those with Medicaid.

A study demonstrates that levels of the CTHRC1 protein in tumor-associated fibroblasts can predict immunotherapy outcomes in ...

Researchers from the Biomedical Data Science Laboratory (BDSLab) at the ITACA Institute of the Universitat Politècnica de València have developed a new method based on magnetic resonance imaging that ...

A group of cancer survivors from around the state is set to gather outside Gov. Kathy Hochul’s Manhattan office on Tuesday.

Tennessee lawmakers have sent a bill that would expand insurance coverage for biomarker testing.

At the Tennessee Capitol, patients, advocates and families came prepared on Tuesday afternoon to tell lawmakers something ...